Frontlight ResearchEarly access
Trial site
Hyogo Prefectural Harima-Himeji General Medical Center
- 7running trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease2 trials
- Antiphospholipid syndrome2 trials
- Dermatomyositis and polymyositis (myositis)2 trials
- Immune thrombocytopenia (ITP)2 trials
- Amyloidosis1 trial
- Eosinophilic oesophagitis1 trial
- Heart failure1 trial
- Lewy body dementia1 trial
- Mild cognitive impairment1 trial
- Obesity1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 33 trials
- Phase 12 trials
- Phase 22 trials
- Status
- Recruiting3 trials
- Active, not recruiting2 trials
- Enrolling by invitation1 trial
- Not yet recruiting1 trial
- Lead sponsor
- Eli Lilly and Company3 trials
- Chugai Pharmaceutical2 trials
- Novo Nordisk A/S1 trial
- Regeneron Pharmaceuticals1 trial
Running trials
Not yet recruiting
Recruiting
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Recruiting
Enrolling by invitation
Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)
Active, not recruiting
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
Recruiting
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Antiphospholipid syndrome2 recruiting
- Dermatomyositis and polymyositis (myositis)2 recruiting
- Immune thrombocytopenia (ITP)2 recruiting
- Alzheimer disease1 recruiting
- Amyloidosis1 recruiting
- Heart failure1 recruiting
- Lewy body dementia1 recruiting
- Mild cognitive impairment1 recruiting
- Obesity1 recruiting
- Type 2 diabetes1 recruiting
Site data: ClinicalTrials.govUpdated 18 Nov 2026